Aside from the implication of TGF-β in the regulation of CD133 expression in cancer (see above), an intriguing relationship between CD133 and TGF-β/Smad signaling has been observed in a study focused on peripheral axon regeneration after crush injury [371]. This evidence concerns the gene PROM1 and cancer.